3ebiovc.cn

What It Is

3E Bioventures is a specialized venture capital fund focused on the healthcare industry. Unlike generalist investment firms, 3E Bioventures concentrates on subsectors such as innovative drug development, medical devices, clinical diagnostics, and healthcare services. The firm manages both RMB and USD funds, giving it cross-border investment capabilities. Its goal is to identify and support globally competitive medical innovation companies and build a healthcare investment brand that grows from China to the world.

Core Dimensions

• Service type: Primary-market equity investment (VC/PE), providing capital support and post-investment value creation rather than payment or transaction settlement services.
• Countries/regions covered: Based in China (Beijing and Shanghai) with overseas reach (Palo Alto, USA), supporting investments in both domestic and international healthcare innovation projects.
• Compliance and licensing: The official website discloses an ICP filing, 京ICP备16004239号, but does not publicly list a private fund manager registration number or other financial license information.
• Risk-control capabilities: Its risk management relies primarily on the team’s professional expertise. The core team has backgrounds in the biopharmaceutical industry and more than ten years of investment and entrepreneurial experience, using deep industry knowledge to mitigate technical and market risks in projects.
• Payments, settlement, and API integration: As an investment firm, it does not provide fintech infrastructure services such as payment gateways, settlement cycles, or API integration.

Pricing and Fees

3E Bioventures is not a commercial SaaS provider or payment service provider, so it does not have a traditional “pricing” or “transaction fee” model. For companies seeking financing, the “cost” of receiving investment from 3E Bioventures is equity dilution. For LPs, the cost typically consists of fund management fees and carried interest.

Pros and Cons

Pros:

1. Deep vertical focus: Dedicated to healthcare, with strong industry understanding and the ability to provide portfolio companies with industrial resources beyond capital.
2. Dual-currency fund advantage: RMB and USD fund structures allow flexible financing support for companies with different corporate setups.
3. Experienced team: Has invested in more than 90 healthcare companies, and the team combines industry and investment experience with strong project-screening capabilities.

Cons:

1. Narrow sector focus: Highly concentrated on healthcare; projects outside this sector are completely outside its investment scope.
2. High entry bar: As a professional VC, it has strict requirements for founding team backgrounds and data milestones, making it difficult for very early-stage projects to secure funding.

Who It’s For

Best suited for startup to growth-stage companies across the healthcare value chain, especially entrepreneurial teams in innovative drug development, medical devices, clinical diagnostics, and healthcare services. It is also suitable for professional institutional investors (LPs) seeking exposure to healthcare assets.

Access from China

3E Bioventures uses a .cn domain and has completed an MIIT ICP filing. Its servers and business entity are located in mainland China, so the website can be accessed directly from China without network restrictions.